- Report
- December 2023
- 200 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- November 2023
- 175 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- May 2023
- 404 Pages
Global
From €4804EUR$5,000USD£4,131GBP
- Report
- March 2024
- 146 Pages
Global
From €3746EUR$3,899USD£3,221GBP
- Report
- October 2023
- 236 Pages
Global
From €5284EUR$5,499USD£4,543GBP
- Report
- April 2024
- 230 Pages
Global
From €2393EUR$2,490USD£2,057GBP
- Report
- October 2023
- 150 Pages
Global
From €4660EUR$4,850USD£4,007GBP
- Report
- October 2023
- 178 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- August 2023
- 117 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Report
- October 2023
- 190 Pages
Global
From €4708EUR$4,900USD£4,048GBP
- Clinical Trials
- April 2024
- 230 Pages
Global
From €2883EUR$3,000USD£2,479GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,239GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1441EUR$1,500USD£1,239GBP
- Report
- February 2024
- 173 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Report
- January 2024
- 158 Pages
Global
From €2402EUR$2,500USD£2,066GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €2883EUR$3,000USD£2,479GBP
- Clinical Trials
- April 2024
- 60 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Drug Pipelines
- April 2024
- 180 Pages
Global
From €1922EUR$2,000USD£1,652GBP
- Drug Pipelines
- April 2024
- 60 Pages
Global
From €1201EUR$1,250USD£1,033GBP
- Report
- December 2023
- 150 Pages
Global
From €3603EUR$3,750USD£3,098GBP
The Ovarian market is a segment of the Women's Health industry that focuses on the diagnosis, treatment, and prevention of ovarian diseases. It includes products and services related to the diagnosis, treatment, and prevention of ovarian cancer, ovarian cysts, and other ovarian disorders. The market also includes products and services related to fertility, contraception, and hormone replacement therapy.
The Ovarian market is driven by the increasing prevalence of ovarian diseases, the growing awareness of the importance of early diagnosis and treatment, and the increasing demand for fertility treatments. Additionally, the development of new technologies and treatments for ovarian diseases is expected to drive the market growth.
Some companies in the Ovarian market include AbbVie, AstraZeneca, Bayer, Merck, Novartis, Pfizer, and Roche. Show Less Read more